Effect of half-dose BYVASDA versus standard dose Avastin combined with mFOLFOX6 chemotherapy on metastatic colorectal cancer : A multicenter, open-label, parallel, randomized controlled clinical study
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/35935
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: experimental group:mFOLFOX6 +half-dose Bevacizumab (BYVASDA);control group:mFOLFOX6 + half-dose Bevacizumab (Avastin)
Primary outcome(s): Progression-Free Survival, PFS
Study Design: Parallel
创建时间：
2022-01-15
